GLPG Stock Earnings: Galapagos Beats EPS, Misses Revenue for Q1 2024 Galapagos (NASDAQ: GLPG ) just reported results for the first quarter of 2024. Galapagos reported earnings per share of $1.52. This was above the analyst estimate for EPS of -4 cents. The company reported revenue of $67.81 million. This was 2.28% worse than the analyst estimate for revenue of $69.39 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. Legendary Investor Predicts: “Forget A.I.
Galapagos Unveils Promising Cancer Therapy Data Galapagos (GLPG) has released an update. Galapagos NV has released promising new data for its CD19 CAR-T candidate, GLPG5101, showing high complete…
Galapagos’ Breakthrough in Non-Hodgkin Lymphoma Treatment Galapagos (GB:0JXZ) has released an update. Galapagos NV has reported promising results for their CD19 CAR-T cell therapy, GLPG5101, in treating re…
Inflammatory Myositis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest Approvals by DelveInsight Inflammatory Myositis companies are Horizon Therapeutics, Merck, Galapagos NV, Alexion Pharmaceuticals, Pfizer, Kezar Life Sciences, and others. LAS VEGAS, NEVADA, UNITED STATES, June 10, 2024 /EINPresswire.com/ -- DelveInsight’s “Inflammatory …
Galapagos NV Announces New Employee Benefits Plan Galapagos NV (UK) (GB:0JXZ) has released an update. Galapagos NV has created over 1.6 million new subscription rights aimed at benefiting its emplo…
Galapagos NV Unveils Employee Subscription Plans Galapagos NV (GLPG) has released an update. Galapagos NV has launched new subscription right plans for its employees, with 1,614,000 rights offered…
Galapagos creates new subscription right plans Mechelen, Belgium; 16 May 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 1,614,000 subscription rights under new subscription right plans for the benefit of certain members of the personnel of the company and its subsidiaries.
Aiming to decentralize CAR-T manufacturing, Galapagos partners with largest US blood supply network … network of decentralized CAR-T manufacturing . The partnership with Blood Centers …
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos' decentralized CAR-T manufacturing network in the U.S. Mechelen, Belgium; 15 May 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and Blood Centers of America (BCA) today announced that they have entered into a strategic collaboration for the decentralized manufacturing of Galapagos' CAR-T cell therapies through BCA's network in the U.S.